| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/26/2011 | US20110123457 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| 05/26/2011 | CA2778432A1 Parenteral formulations of gemcitabine derivatives |
| 05/25/2011 | EP2324043A1 Nucleoside derivatives as inhibitors of viral polymerases |
| 05/25/2011 | EP2324042A1 Process for preparing azacytidine intermediate |
| 05/25/2011 | CN102070691A Metacavir crystal form, preparation method thereof and medicinal composition containing metacavir crystal form |
| 05/25/2011 | CN102070690A Method for preparing adenosine, cordycepin and N6-(2-hydroxyethyl)adenosine simultaneously used as chemical reference substances |
| 05/25/2011 | CN102070679A 1-acetoxyl-2-deoxy-3, 5-di-O-fluorenylmethyloxycarbonyl acyl-D-ribofuranose and application |
| 05/25/2011 | CN101584672B Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 05/25/2011 | CN101260135B Method for synthesizing higher fatty acid zidovudine ester |
| 05/25/2011 | CN101240003B Method for preparing clofarabine raw material medicament |
| 05/24/2011 | US7947824 Process for preparing purine nucleosides |
| 05/24/2011 | US7947818 Heteromolecular metal-humic (chelate) complexes |
| 05/24/2011 | US7947817 Nucleotide blocked with sugar compound; biosynthesis of nucleic acids |
| 05/24/2011 | CA2482945C Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 05/19/2011 | WO2011003018A3 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| 05/19/2011 | US20110118455 Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method |
| 05/19/2011 | US20110118438 Cyanine-type compounds having an alkynyl linker arm |
| 05/19/2011 | US20110118203 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound |
| 05/19/2011 | US20110117054 Use of ribavirin in blood coagulation disorder |
| 05/19/2011 | CA2781054A1 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
| 05/18/2011 | EP2322534A1 Antiviral nucleosides |
| 05/18/2011 | EP2322525A1 Purine derivatives for use as adenosin A2A receptor agonists |
| 05/18/2011 | EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 05/18/2011 | EP2322187A2 Use of uridine in combination with choline for the treatment of memory disorders |
| 05/18/2011 | EP2321330A1 Method for producing phosphate-bridged nucleoside conjugates |
| 05/18/2011 | EP2321302A2 Azacitidine process and polymorphs |
| 05/18/2011 | CN102066393A Novel synthesis of galactoside inhibitors |
| 05/18/2011 | CN102060900A Technological process for extracting cyclic adenosine monophosphate (CAMP) from red dates |
| 05/18/2011 | CN102060899A Nelarabine N-9 site alpha isomer, and preparation method and application thereof |
| 05/18/2011 | CN102060898A Extraction method of cordycepin |
| 05/18/2011 | CN101023094B Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 05/17/2011 | US7943788 Glucopyranoside compound |
| 05/17/2011 | US7943760 Non-nucleotide composition for inhibiting platelet aggregation |
| 05/17/2011 | US7943759 3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof |
| 05/17/2011 | US7943758 3′-end nucleoside unit comprising phosphoramidite |
| 05/17/2011 | CA2437994C Crystalline forms of pyrimidine nucleoside derivative |
| 05/12/2011 | WO2011054289A1 Epirubicin derivatives |
| 05/12/2011 | WO2011054179A1 Crystalline form of cladribine and process for preparation thereof |
| 05/12/2011 | US20110112046 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/11/2011 | EP2319856A1 Methods and compositions for treating hepatitis c virus |
| 05/11/2011 | EP2319855A1 Bioconjugation of Macromolecules |
| 05/11/2011 | EP2319854A1 Bioconjugation Of Macromolecules |
| 05/11/2011 | EP2319853A1 Process for the production of 2'-branched nucleosides |
| 05/11/2011 | EP2318423A1 Process for making 5-azacytosine nucleosides and their derivatives |
| 05/11/2011 | CN1931869B Derivative of 5-deoxy-5-fluoro cytidine and its preparation process and use |
| 05/11/2011 | CN102050857A Method for synthesizing 5-methyluridine |
| 05/11/2011 | CN102050856A High-activity epirubicin derivative, preparation method thereof and application thereof |
| 05/11/2011 | CN101525362B Preparation method of 5'-deoxidization-2',3'-diacetyl-5-fluoro-cytidine |
| 05/11/2011 | CN101302239B Synthetic method of telbivudine and intermediate thereof |
| 05/10/2011 | US7939651 Modified Cry35 proteins |
| 05/10/2011 | CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 05/05/2011 | WO2011052436A1 Bridged artificial nucleoside and nucleotide |
| 05/05/2011 | WO2011051733A2 Compounds and their uses in protein binding assays |
| 05/05/2011 | WO2010135564A3 Novel compounds and derivatization of dnas and rnas on the nucleobases of pyrimidines for function, structure, and therapeutics |
| 05/05/2011 | US20110105425 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105362 Cyanine compounds and their application as quenching compounds |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | CA2778171A1 Bridged artificial nucleoside and nucleotide |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP1348712B1 Processes and intermediates in the synthesis of L-thymidine |
| 05/04/2011 | EP1163369B1 Sequencing by incorporation |
| 05/04/2011 | CN102046645A Crystal of spiroketal derivative, and process for production thereof |
| 05/04/2011 | CN102046626A Carba-nucleoside analogs for antiviral treatment |
| 05/04/2011 | CN101508715B Extraction and purification process for cordycepin in cordyceps militaris link |
| 05/04/2011 | CN101250194B L-nucleic acid derivative and processes for the synthesis thereof |
| 05/03/2011 | US7935814 Nitroguanosine-3′ 5′-cyclic monophosphate compound and protein kinase G activating agent |
| 05/03/2011 | US7935681 Antiviral nucleosides |
| 05/03/2011 | US7935680 Methods for modulating the axonal growth of central nervous system neurons |
| 05/03/2011 | US7935674 Indole derivatives |
| 05/03/2011 | CA2469649C Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 04/28/2011 | WO2011048148A2 Glycoside derivative and uses thereof |
| 04/28/2011 | WO2011048040A1 Method and formulation for the control of parasites |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098294 Purine analogs |
| 04/28/2011 | US20110098243 Ectonucleotidase pyrophosphate/phosphodiesterase-1 (enpp-1) as a target for the treatment of aortic valve stenosis and cardiovascular calcification |
| 04/28/2011 | US20110097762 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| 04/28/2011 | US20110097727 Dna markers for management of cancer |
| 04/28/2011 | CA2778384A1 Glycoside derivative and uses thereof |
| 04/27/2011 | EP2314594A1 6-modified bicyclic nucleic acid analogs |
| 04/27/2011 | EP2313422A2 Nucleoside cyclicphosphates |
| 04/27/2011 | EP2313102A2 Bycyclic nucleosides and nucleotides as therapeutic agents |
| 04/27/2011 | CN102037003A Method of producing 2'-deoxy-5-azacytidine (decitabine) |
| 04/27/2011 | CN102030792A 3'-o-fluorescently modified nucleotides and uses thereof |
| 04/27/2011 | CN101265284B Method for synthesizing clofarabine |
| 04/26/2011 | US7932376 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation |
| 04/26/2011 | CA2439085C Methods for identifying ligand binding sites in a biomolecule |
| 04/21/2011 | WO2008104893A3 Nucleoside derivatives useful for the treatment or prevention of viral infections and methods of use thereof |
| 04/21/2011 | WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 04/21/2011 | US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance |
| 04/21/2011 | US20110092694 Synthesis of 5-azacytidine |
| 04/21/2011 | US20110092574 mRNA Cap Analogs |
| 04/21/2011 | US20110092570 Oligomeric compounds comprising tricyclic nucelosides and methods for their use |
| 04/21/2011 | US20110092451 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 04/21/2011 | US20110091887 Method for detection of methylcytosine using photoresponsive probe |
| 04/21/2011 | US20110091726 PARTICULATE COMPOSITION CONTAINING ANHYDROUS CRYSTALLINE 2-O-alpha-D-GLUCOSYL-L-ASCORBIC ACID, PROCESS FOR PRODUCING THE SAME, AND USES THEREOF |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/20/2011 | EP2311466A2 Antimicrobial compounds and methods for their use |
| 04/20/2011 | EP2310401A1 Universal methylation profiling methods |